Home › Free Stock Grades › MGNX
MacroGenics, Inc. (MGNX) Stock Grade
MGNX · Healthcare
C
Market Cap
$258.1M
P/E Ratio
—
Revenue Growth (YoY)
+0.8%
Net Margin
-49.9%
Return on Equity
—
Dividend Yield
None
About MacroGenics, Inc.'s fundamentals
MacroGenics is a biotechnology company with a market capitalization of $258.1 million that reported minimal revenue growth of 0.8% year-over-year and currently operates at a significant loss, with a net margin of -49.9%. The company does not pay a dividend and reported a net loss in its latest annual statement, indicating it is in a development or pre-profitability stage typical of many early-stage biotech firms. With such substantial negative margins, the company is burning through capital rather than generating profits, which is characteristic of biotechnology companies investing heavily in research and drug development.